In vitro degradation of zearalenone by Bacillus subtilis.
Summary of "In vitro degradation of zearalenone by Bacillus subtilis."
Zearalenone (ZEN) is a non-steroidal estrogen produced by many Fusarium species in cereals and other plants, and is frequently implicated in safety of foods and feeds. A ZEN-degrading microorganism has been isolated and identified as a Bacillus subtilis subspecies. It degraded 99% ZEN (1 mg kg(-1)) in liquid medium after 24 h and more than 95% of ZEN (0.25 mg kg(-1)) could be degraded after 48 h in a solid-state fermentation. This isolate can thus be used to decontaminate raw materials, like grains, to reduce the mycotoxin concentration.
Department of Food Science and Technology, Chungnam National University, Daejeon, 305-764, Republic of Korea.
This article was published in the following journal.
Name: Biotechnology letters
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20697929
- DOI: http://dx.doi.org/10.1007/s10529-010-0373-y
The purpose of this research was to investigate the toxicity of zearalenone (ZEA) on the growing performance, genital organs, serum hormones and histopathological changes of pre-pubertal female gilts,...
Bacillus subtilis has tremendous applications in both academic research and industrial production. However, molecular cloning and transformation of B. subtilis are not as easy as those of Escherichia ...
Bacillus cyclic lipopeptides (LPs) have been well-studied for their phytopathogen antagonistic activities. Recently, researches showed that these LPs also contributed to the phenotypic features of Bac...
Rice blast, caused by Magnaporthe grisea threatens rice production worldwide. It is important to develop novel and environment-safe strategies to control the fungus. Here we reported that Bacillus sub...
Biodesulfurization of the model oil using Rhodococcus erythropolis PTCC1767 (R. erythropolis) and Bacillus subtilis DSMZ 3256 (B. subtilis) strains assisted by applying electrokinetic was investigated...
Primary objective: - To demonstrate the efficacy of a Bacillus clausii probiotic strain compared to placebo in children suffering from acute diarrhoea and treated for 7 days. ...
To determine the effectiveness of the pre-biotic Bacillus clausii in preventing antibiotic associated diarrhea among hospitalized immunocompetent Filipino children.
To assess the effects of Bacillus clausii (Enterogermina®) on fecal microbial flora (using Polymerase Chain Reaction - Denaturing Gradient Gel Electrophoresis - PCR-DGGE - Method) in ant...
Primary: - To demonstrate the efficacy of Enterogermina® in reducing the duration of acute diarrhea in children Secondary: - To evaluate the safety of Enterogerm...
The purpose of this study is to determine if treatment with the autologous cellular vaccine, Melaxin, in combination with Bacillus Calmette-Guerin (BCG) injections is effective in Stage I...
Medical and Biotech [MESH] Definitions
A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-
A species of gram-positive bacteria that is a common soil and water saprophyte.
A cyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis that acts as an antifungal agent.
A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. (From Enzyme Nomenclature, 1992) EC 126.96.36.199.
A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)